dc.contributor.author | Ononge, Sam | |
dc.contributor.author | Karamagi, Charles | |
dc.contributor.author | Nakabiito, Clemensia | |
dc.contributor.author | Wandabwa, Julius | |
dc.contributor.author | Mirembe, Florence | |
dc.contributor.author | Rukundo, Godfrey Zari | |
dc.contributor.author | Jennings, Larissa | |
dc.date.accessioned | 2022-07-15T13:21:33Z | |
dc.date.available | 2022-07-15T13:21:33Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Ononge, S., Karamagi, C., Nakabiito, C., Wandabwa, J., Mirembe, F., Rukundo, G. Z., & Jennings, L. (2014). Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda. International Journal of Gynecology & Obstetrics, 124(3), 235-239. | en_US |
dc.identifier.uri | http://ir.must.ac.ug/xmlui/handle/123456789/2240 | |
dc.description.abstract | Objective: To determine factors associated with an unknown HIV serostatus among pregnant women admitted in labor to Mulago Hospital, Kampala, Uganda.
Methods: In total, 665 pregnant women admitted to Mulago Hospital were interviewed about their sociodemographic characteristics, obstetric history, access to prenatal care, fears regarding HIV testing, and knowledge about modes of mother-to-child-transmission (MTCT). Knowledge of the HIV serostatus was assessed by self-report and verified by prenatal card review.
Results: The prevalence of unknown HIV serostatus at the time of labor was 27.1%. Factors associated with an unknown HIV serostatus included high parity (odds ratio [OR] 1.9; 95% confidence interval [CI], 1.16–3.14), preterm delivery (OR 2.60; 95% CI, 1.06–6.34), prenatal care at a private clinic (OR 12.87; 95% CI, 5.68–29.14), residence more than 5 km from the nearest prenatal clinic (OR 2.86; 95% CI, 1.18–17.9), high knowledge about MTCT (OR 0.25; 95% CI, 0.07–0.86), and fears related to disclosing the test result to the partner (OR 3.60; 95% CI, 1.84–7.06).
Conclusion: The high prevalence of unknown HIV serostatus among women in labor highlights the need to improve accessibility to HIV testing services early during pregnancy to be able to take advantage of antiretroviral therapy. | en_US |
dc.description.sponsorship | Grant number 5R24TW00 8886 supported by the Office of the US Global Aids Coordinator, the National Institutes of Health, and the Health Resources and Service Administration | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | International Journal of Gynecology and Obstetrics | en_US |
dc.subject | Delivery | en_US |
dc.subject | Labor | en_US |
dc.subject | Prevention of mother-to-child transmission | en_US |
dc.subject | Unknown HIV serostatus | en_US |
dc.title | Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda | en_US |
dc.type | Article | en_US |